Steven M. Johnson

2.7k total citations
49 papers, 2.0k citations indexed

About

Steven M. Johnson is a scholar working on Molecular Biology, Materials Chemistry and Oncology. According to data from OpenAlex, Steven M. Johnson has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Materials Chemistry and 9 papers in Oncology. Recurrent topics in Steven M. Johnson's work include Heat shock proteins research (14 papers), Alzheimer's disease research and treatments (7 papers) and Protein Structure and Dynamics (6 papers). Steven M. Johnson is often cited by papers focused on Heat shock proteins research (14 papers), Alzheimer's disease research and treatments (7 papers) and Protein Structure and Dynamics (6 papers). Steven M. Johnson collaborates with scholars based in United States, France and United Kingdom. Steven M. Johnson's co-authors include Jeffery W. Kelly, Stephen Connelly, Ian A. Wilson, Evan T. Powers, Colleen Fearns, N. C. Baenziger, D. Coucouvanis, R. Luke Wiseman, Yoshiki Sekijima and Sara L. Adamski‐Werner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Steven M. Johnson

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven M. Johnson United States 24 1.2k 439 362 335 294 49 2.0k
Chittaranjan Das United States 28 1.8k 1.5× 278 0.6× 323 0.9× 349 1.0× 266 0.9× 83 2.5k
I.W. McNae United Kingdom 26 1.1k 0.9× 371 0.8× 60 0.2× 345 1.0× 134 0.5× 46 1.8k
Huchen Zhou China 27 1.7k 1.5× 980 2.2× 46 0.1× 314 0.9× 173 0.6× 54 2.9k
Hemalatha Balaram India 26 1.5k 1.3× 339 0.8× 304 0.8× 86 0.3× 58 0.2× 104 2.1k
Giovanna Boumis Italy 23 731 0.6× 132 0.3× 264 0.7× 76 0.2× 110 0.4× 39 1.4k
Robert T. Jacobs United States 27 755 0.6× 625 1.4× 149 0.4× 208 0.6× 41 0.1× 43 1.9k
Susan A. Martinis United States 28 2.4k 2.0× 214 0.5× 53 0.1× 221 0.7× 251 0.9× 61 3.1k
Konstantinos Thalassinos United Kingdom 32 1.7k 1.5× 154 0.4× 103 0.3× 112 0.3× 177 0.6× 86 3.3k
James H. Freisheim United States 29 1.8k 1.5× 559 1.3× 89 0.2× 260 0.8× 167 0.6× 124 2.8k
Erich Hochuli Switzerland 14 2.1k 1.8× 226 0.5× 64 0.2× 257 0.8× 164 0.6× 20 2.9k

Countries citing papers authored by Steven M. Johnson

Since Specialization
Citations

This map shows the geographic impact of Steven M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Johnson more than expected).

Fields of papers citing papers by Steven M. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Johnson. The network helps show where Steven M. Johnson may publish in the future.

Co-authorship network of co-authors of Steven M. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Johnson. A scholar is included among the top collaborators of Steven M. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Johnson. Steven M. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sivinski, Jared, Edmond R. Watson, Wenli Xu, et al.. (2024). Bis-sulfonamido-2-phenylbenzoxazoles Validate the GroES/EL Chaperone System as a Viable Antibiotic Target. Journal of the American Chemical Society. 146(30). 20845–20856. 3 indexed citations
2.
Schworer, Stephen A., et al.. (2023). ANCA vasculitis expands the spectrum of autoimmune manifestations of activated PI3 kinase δ syndrome. Frontiers in Pediatrics. 11. 1179788–1179788. 4 indexed citations
3.
Ridge, Perry G., et al.. (2023). Short Sequence Aligner Benchmarking for Chromatin Research. International Journal of Molecular Sciences. 24(18). 14074–14074. 1 indexed citations
4.
Ray, Anne‐Marie, Emma H. Doud, Jared Sivinski, et al.. (2022). Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol. Bioorganic & Medicinal Chemistry. 75. 117072–117072. 5 indexed citations
5.
Ray, Anne‐Marie, Nilshad Salim, Sanofar Abdeen, et al.. (2021). Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer. Bioorganic & Medicinal Chemistry. 40. 116129–116129. 12 indexed citations
6.
Abdeen, Sanofar, Nilshad Salim, Anne‐Marie Ray, et al.. (2019). HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules. PMC. 1 indexed citations
7.
Abdeen, Sanofar, Nilshad Salim, Anne‐Marie Ray, et al.. (2019). HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules. Bioorganic & Medicinal Chemistry Letters. 29(9). 1106–1112. 22 indexed citations
8.
Abdeen, Sanofar, Yulia Ovechkina, Anne‐Marie Ray, et al.. (2019). Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections. Bioorganic & Medicinal Chemistry Letters. 29(13). 1665–1672. 14 indexed citations
9.
Wu, Chunxiang, Jingling Liao, Yangshin Park, et al.. (2019). Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics. Journal of Biological Chemistry. 294(15). 5907–5913. 17 indexed citations
10.
Ambrose, Andrew J., Jared Sivinski, Cody J. Schmidlin, et al.. (2019). A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78. Bioorganic & Medicinal Chemistry Letters. 29(14). 1689–1693. 15 indexed citations
11.
Connelly, Stephen, D.E. Mortenson, Sungwook Choi, et al.. (2017). Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(15). 3441–3449. 6 indexed citations
12.
Johnson, Steven M., Puiying A. Mak, Ingo H. Engels, et al.. (2014). A biochemical screen for GroEL/GroES inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(3). 786–789. 34 indexed citations
13.
Vidadala, Rama Subba Rao, Kayode K. Ojo, Steven M. Johnson, et al.. (2014). Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes. European Journal of Medicinal Chemistry. 74. 562–573. 48 indexed citations
14.
Ojo, Kayode K., Claudia Pfander, Natascha Mueller, et al.. (2012). Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors. Journal of Clinical Investigation. 122(6). 2301–2305. 78 indexed citations
15.
Johnson, Steven M., Stephen Connelly, Colleen Fearns, Evan T. Powers, & Jeffery W. Kelly. (2012). The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug. Journal of Molecular Biology. 421(2-3). 185–203. 257 indexed citations
16.
Zhang, Zhongsheng, Kayode K. Ojo, Steven M. Johnson, et al.. (2012). Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1. Bioorganic & Medicinal Chemistry Letters. 22(16). 5264–5267. 38 indexed citations
17.
Connelly, Stephen, Sungwook Choi, Steven M. Johnson, Jeffery W. Kelly, & Ian A. Wilson. (2010). Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Current Opinion in Structural Biology. 20(1). 54–62. 143 indexed citations
18.
Choi, Sungwook, Natàlia Reixach, Stephen Connelly, et al.. (2009). A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and Cytotoxicity. Journal of the American Chemical Society. 132(4). 1359–1370. 63 indexed citations
19.
Johnson, Steven M., Stephen Connelly, Ian A. Wilson, & Jeffery W. Kelly. (2008). Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies. Journal of Medicinal Chemistry. 51(20). 6348–6358. 63 indexed citations
20.
Johnson, Steven M. & Glenn D. Roberts. (1987). In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex. Diagnostic Microbiology and Infectious Disease. 7(1). 89–91. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026